Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
Frankfurt - Delayed Quote EUR

Nevro Corp. (1N7.F)

Compare
5.30
0.00
(0.00%)
At close: April 2 at 8:00:15 AM GMT+2
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
408,518
408,518
425,174
406,365
386,905
Cost of Revenue
138,990
138,990
135,114
129,998
120,863
Gross Profit
269,528
269,528
290,060
276,367
266,042
Operating Expense
364,228
364,228
389,368
375,203
356,976
Operating Income
-94,700
-94,700
-99,308
-98,836
-90,934
Net Non Operating Interest Income Expense
-13,583
-13,583
6,152
-2,411
-19,078
Other Income Expense
-4,063
-4,063
-4,703
105,511
-20,814
Pretax Income
-112,346
-112,346
-97,859
4,264
-130,826
Tax Provision
1,093
1,093
-5,646
1,263
534
Net Income Common Stockholders
-113,439
-113,439
-92,213
3,001
-131,360
Diluted NI Available to Com Stockholders
-113,439
-113,439
-92,213
3,001
-131,360
Basic EPS
-1.87
-3.06
-2.56
0.08
-3.77
Diluted EPS
-1.87
-3.06
-2.56
0.08
-3.77
Basic Average Shares
36,752.74
37,088.48
35,981.43
35,317.64
34,823.26
Diluted Average Shares
36,752.74
37,088.48
35,981.43
35,525.26
34,823.26
Total Operating Income as Reported
-126,229
-126,229
-99,308
6,164
-110,934
Total Expenses
503,218
503,218
524,482
505,201
477,839
Net Income from Continuing & Discontinued Operation
-113,439
-113,439
-92,213
3,001
-131,360
Normalized Income
-110,561.82
-110,561.82
-88,333.53
-70,919
-116,760
Interest Income
13,304
13,304
14,166
4,021
671
Interest Expense
26,887
26,887
8,014
6,432
19,749
Net Interest Income
-13,583
-13,583
6,152
-2,411
-19,078
EBIT
-85,459
-85,459
-89,845
10,696
-111,077
EBITDA
-71,345
-71,345
-78,310
21,023
-102,399
Reconciled Cost of Revenue
127,824
127,824
123,825
119,671
112,185
Reconciled Depreciation
14,114
14,114
11,535
10,327
8,678
Net Income from Continuing Operation Net Minority Interest
-113,439
-113,439
-92,213
3,001
-131,360
Total Unusual Items Excluding Goodwill
-3,642
-3,642
-4,117
105,000
-20,000
Total Unusual Items
-3,642
-3,642
-4,117
105,000
-20,000
Normalized EBITDA
-67,703
-67,703
-74,193
-83,977
-82,399
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-764.82
-764.82
-237.53
31,080
-5,400
12/31/2021 - 4/28/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

S1YK34.SA Stryker Corporation
101.76
-2.07%
 
BIO-B Bio-Rad Laboratories, Inc.
241.99
0.00%
 
ITGR Integer Holdings Corporation
113.70
-2.04%
 
LIVN LivaNova PLC
35.95
-4.08%
 
IART Integra LifeSciences Holdings Corporation
19.57
-2.44%
 
STE STERIS plc
212.61
-3.97%
 
SNN Smith & Nephew plc
26.31
-5.83%
 
NARI Inari Medical, Inc.
79.97
0.00%
 
GKOS Glaukos Corporation
83.65
-3.85%
 
PODD Insulet Corporation
245.26
-4.49%